Fullerton, CALIFORNIA4 Active Studies

Advanced Solid Tumors Clinical Trials in Fullerton, CALIFORNIA

Find 4 actively recruiting advanced solid tumors clinical trials in Fullerton, CALIFORNIA. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
4,097
Enrolling

Recruiting Advanced Solid Tumors Studies in Fullerton

RecruitingFullerton, CALIFORNIANCT03486873

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

The purpose of this study is to evaluate the long-term safety and efficacy of pembrolizumab (MK-3475) in participants from previous Merck pembrolizumab-based parent studies who transition into this ex...

3,500 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingFullerton, CALIFORNIANCT05083481

A Study of ASP1570 Alone or in Combination With Pembrolizumab or Standard Therapies in Adults With Solid Tumors

Immune therapies work with the body's immune system to treat a number of cancers. They work with T-cells, a type of white blood cell, to target and attack specific tumors. However, some tumors can bec...

310 participants
Astellas Pharma Global Development, Inc.
View Study Details
RecruitingFullerton, CALIFORNIANCT06747585

A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetic, pharmacodynamic, preliminary anti-tumor activity, and to determine the recommended Phase II dose (RP2D) of the ALE.P...

170 participants
Alentis Therapeutics AG
View Study Details
RecruitingFullerton, CALIFORNIANCT06425926

Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors

GIM-531 is a first-in-class, orally bioavailable small molecule that is being developed for the treatment of advanced solid tumors as a single agent and rescue therapy. GIM-531 exhibits its primary ef...

117 participants
Georgiamune Inc
View Study Details

About Advanced Solid Tumors Clinical Trials in Fullerton

Advanced solid tumors refer to cancers that have grown beyond the original site or spread to distant organs. Many clinical trials enroll patients with various types of advanced solid tumors to test novel therapies. These trials often investigate immunotherapy, targeted therapy, and combination approaches.

There are currently 4 advanced solid tumors clinical trials recruiting participants in Fullerton, CALIFORNIA. These studies are seeking a combined 4,097 participants. Research is being sponsored by Merck Sharp & Dohme LLC, Astellas Pharma Global Development, Inc., Alentis Therapeutics AG and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Advanced Solid Tumors Clinical Trials in Fullerton — FAQ

Are there advanced solid tumors clinical trials in Fullerton?

Yes, there are 4 advanced solid tumors clinical trials currently recruiting in Fullerton, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Fullerton?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fullerton research site will contact you about next steps.

Are clinical trials in Fullerton free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fullerton studies also compensate for your time and travel.

What advanced solid tumors treatments are being tested?

The 4 active trials in Fullerton are testing new therapies including novel drugs, biologics, and treatment approaches for advanced solid tumors.

Data updated March 2, 2026 from ClinicalTrials.gov